All publications of “Fabio Rodrigues Kerbauy”

4 results

Predicting mortality and cost of hematopoeitic stem-cell transplantation

Fábio Rodrigues Kerbauy, Leonardo Raul Morelli, Cláudia Toledo de Andrade, Luis Fernando Lisboa, Miguel Cendoroglo Neto, Nelson Hamerschlak

DOI: 10.1590/S1679-45082012000100017

Objective:To evaluate whether the Pretransplantion Assesment of Mortality risk score is associated to transplant costs and can be used not only to predict mortality but also as a cost management tool.METHODS:We evaluated consecutively patients submitted to allogeneic (n = 27) and autologous (n = 89) hematopoietic stem cell-transplantation from 2004 to 2006 at Hospital Israelita Albert Einstein (SP), Brazil. Participants mean age at hematopoietic stem cell-transplantation was 42 (range 1 to 72) years; there were 69 males and 47 females; […]

Allogeneic hematopoietic stem cell transplantation in children with primary immunodeficiencies: Hospital Israelita Albert Einstein experience

Juliana Folloni Fernandes, Fabio Rodrigues Kerbauy, Andreza Alice Feitosa Ribeiro, Jose Mauro Kutner, Luis Fernando Aranha Camargo, Adalberto Stape, [...]

DOI: 10.1590/S1679-45082011AO2007

ABSTRACT Objective: To report the experience of a tertiary care hospital with allogeneic hematopoietic stem cell transplantation in children with primary immunodeficiencies. Methods: Seven pediatric patients with primary immunodeficiencies (severe combined immunodeficiency: n = 2; combined immunodeficiency: n = 1; chronic granulomatous disease: n = 1; hyper-IgM syndrome: n = 2; and IPEX syndrome: n = 1) who underwent eight hematopoietic stem cell transplants in a single center, from 2007 to 2010, were studied. Results: Two patients received transplants from […]

Hodgkin’s disease and pregnancy: case series and proposal for treatment protocol

Carolina Kassab, Guilherme Fleury Perini, Patrícia Weinschenker Bollmann, Fabio Rodrigues Kerbauy, Nelson Hamerschlak

DOI: 10.1590/S1679-45082011RC1992

ABSTRACT The peak frequency of Hodgkin’s disease convergesmatches with women of reproductive fertility age. Currently, this disease is the fourth more diagnosed neoplasia during pregnancy. In addition, there is no consensus in the literature on how to treat pregnant women because of the risks of chemotherapy for mothers and for fetuses. We report three cases of pregnant women with Hodgkin’s disease. A review of the literature was made aiming to suggest a protocol to treat these patients.

Autologous stem-cell transplantation for multiple myeloma: a Brazilian institution experience in 15 years of follow-up

Juliana Todaro, Ana Rita de Araújo Burgos Manhani, José Mauro Kutner, Andreza Alice Feitosa Ribeiro, Morgani Rodrigues, Fabio Rodrigues Kerbauy, [...]

DOI: 10.1590/S1679-45082011AO1845

ABSTRACT Objective: To determine the 5-year post-transplant survival of patients with multiple myeloma. Methods: A retrospective study in patients diagnosed with multiple myeloma submitted to autologous bone marrow transplantation at a Brazilian institution, during the period of 1993 to 2007. Results: Seventy-three patients were evaluated with a median age of 55 years. Survival in 5 years was 75% (2.4 to 60 months). Statistical analysis demonstrated statistical significance for the applied grade of response prior to treatment with autologous bone marrow […]